Literature DB >> 14638582

Major depression and associated impairment: same or different genetic and environmental risk factors?

Debra L Foley1, Michael C Neale, Charles O Gardner, Andrew Pickles, Carol A Prescott, Kenneth S Kendler.   

Abstract

OBJECTIVE: Impairment was added as a diagnostic criterion for many psychiatric disorders in DSM-IV. Does the addition of impairment influence only prevalence rates, or does it also introduce new etiological factors into psychiatric diagnoses?
METHOD: A lifetime history of major depression and associated functional impairment was assessed by personal interview with 3,669 female and 4,377 male twins from the population-based Virginia Twin Registry. Structural equation modeling was used to estimate the correlation between risk factors for major depression and associated functional impairment.
RESULTS: While the risk factors for major depression and associated functional impairment are substantially correlated, they are not identical. The most parsimonious model suggests that over a quarter of the variance in associated functional impairment is due to factors unrelated to risk for major depression. Of the variance unique to associated functional impairment, approximately one-third is familial. The relationship between associated functional impairment and major depression did not differ significantly between men and women.
CONCLUSIONS: Risk factors for major depression and associated functional impairment are substantially but imperfectly correlated. The addition of associated functional impairment as a criterion for the diagnosis of major depression not only lowers prevalence estimates but also introduces a small set of new etiological factors into the diagnosis of major depression.

Entities:  

Mesh:

Year:  2003        PMID: 14638582     DOI: 10.1176/appi.ajp.160.12.2128

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  12 in total

1.  The relationship between separation anxiety and impairment.

Authors:  Debra L Foley; Richard Rowe; Hermine Maes; Judy Silberg; Lindon Eaves; Andrew Pickles
Journal:  J Anxiety Disord       Date:  2007-06-19

2.  Reasons to be cheerful? Reflections on GPs' responses to depression.

Authors:  Christopher Dowrick
Journal:  Br J Gen Pract       Date:  2009-09       Impact factor: 5.386

Review 3.  Integrating neuroimmune systems in the neurobiology of depression.

Authors:  Eric S Wohleb; Tina Franklin; Masaaki Iwata; Ronald S Duman
Journal:  Nat Rev Neurosci       Date:  2016-06-09       Impact factor: 34.870

4.  Depression: beyond the disease era.

Authors:  Christopher Dowrick
Journal:  London J Prim Care (Abingdon)       Date:  2009

Review 5.  Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.

Authors:  J C Felger; F E Lotrich
Journal:  Neuroscience       Date:  2013-05-03       Impact factor: 3.590

Review 6.  Gene-environment interactions in geriatric depression.

Authors:  Francis E Lotrich
Journal:  Psychiatr Clin North Am       Date:  2011-06

7.  Patient-Centered Research to Support the Development of the Symptoms of Major Depressive Disorder Scale (SMDDS): Initial Qualitative Research.

Authors:  Kelly P McCarrier; Linda S Deal; Lucy Abraham; Steven I Blum; Elizabeth Nicole Bush; Mona L Martin; Michael E Thase; Stephen Joel Coons
Journal:  Patient       Date:  2016-04       Impact factor: 3.883

8.  Three-pronged assessment and diagnosis of personality disorder and its consequences: personality functioning, pathological traits, and psychosocial disability.

Authors:  Lee Anna Clark; Eunyoe Ro
Journal:  Personal Disord       Date:  2014-01

9.  The DSM-IV definition of severity of major depression: inter-relationship and validity.

Authors:  V Lux; S H Aggen; K S Kendler
Journal:  Psychol Med       Date:  2010-01-08       Impact factor: 7.723

10.  Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-α treatment.

Authors:  Francis E Lotrich; Salwa Albusaysi; Robert E Ferrell
Journal:  Neuropsychopharmacology       Date:  2012-12-18       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.